Fourier transform infrared spectroscopy and metabolic profiling in lung cancer

P. Kloer; R. Ghosal; Luis Alejandro Jose Mur; K. E. Lewis; P. D. Lewis

Fourier transform infrared spectroscopy and metabolic profiling in lung cancer

P. Kloer, R. Ghosal, Luis Alejandro Jose Mur, K. E. Lewis, P. D. Lewis

Department of Life Sciences

Research output: Chapter in Book/Report/Conference proceeding › Conference Proceeding (Non-Journal item)

Abstract

Introduction: We have shown that sputum is a feasible biofluid for analysis of biomarkers using Fourier transform infrared (FTIR) spectroscopic analysis and that FTIR can detect different patterns of metabolites between patients with lung cancer and healthy volunteers.1 Aim: To analyse further the FTIR spectrometric patterns in more patients with lung cancer and also smokers deemed 'high risk'. To identify what actual compounds may differentiate cancer from non-cancer sputum samples. Methods: Loco-regional ethical permission was obtained.

Original language	English
Title of host publication	Winter Meeting of the British-Thoracic-Society
Pages	A60-A61
Publication status	Published - 01 Dec 2008
Event	Winter Meeting of the British-Thoracic-Society - London, United Kingdom of Great Britain and Northern Ireland Duration: 03 Dec 2008 → 05 Dec 2008

Conference

Conference	Winter Meeting of the British-Thoracic-Society
Country/Territory	United Kingdom of Great Britain and Northern Ireland
City	London
Period	03 Dec 2008 → 05 Dec 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

http://hdl.handle.net/2160/2410

Permanent link

Persistent link

Cite this

@inproceedings{14e7fd5fd74b4ec08725d8dc889b7fb2,

title = "Fourier transform infrared spectroscopy and metabolic profiling in lung cancer",

abstract = "Introduction: We have shown that sputum is a feasible biofluid for analysis of biomarkers using Fourier transform infrared (FTIR) spectroscopic analysis and that FTIR can detect different patterns of metabolites between patients with lung cancer and healthy volunteers.1 Aim: To analyse further the FTIR spectrometric patterns in more patients with lung cancer and also smokers deemed 'high risk'. To identify what actual compounds may differentiate cancer from non-cancer sputum samples. Methods: Loco-regional ethical permission was obtained.",

author = "P. Kloer and R. Ghosal and Mur, {Luis Alejandro Jose} and Lewis, {K. E.} and Lewis, {P. D.}",

note = "Mur, L. A. J., Kloer, P., Ghosal, R., Lewis, K. E., Lewis, P. D. (2008). Fourier transform infrared spectroscopy and metabolic profiling in lung cancer. Thorax, 63, (Suppl. 7), A60-A61. Spoken session, Winter Meeting of the British Thoracic Society London, UK, 3-5 December, 2008. Thorax, 63 (7) A60-A61 ; Winter Meeting of the British-Thoracic-Society ; Conference date: 03-12-2008 Through 05-12-2008",

year = "2008",

month = dec,

day = "1",

language = "English",

pages = "A60--A61",

booktitle = "Winter Meeting of the British-Thoracic-Society",

}

TY - GEN

T1 - Fourier transform infrared spectroscopy and metabolic profiling in lung cancer

AU - Kloer, P.

AU - Ghosal, R.

AU - Mur, Luis Alejandro Jose

AU - Lewis, K. E.

AU - Lewis, P. D.

N1 - Mur, L. A. J., Kloer, P., Ghosal, R., Lewis, K. E., Lewis, P. D. (2008). Fourier transform infrared spectroscopy and metabolic profiling in lung cancer. Thorax, 63, (Suppl. 7), A60-A61. Spoken session, Winter Meeting of the British Thoracic Society London, UK, 3-5 December, 2008. Thorax, 63 (7) A60-A61

PY - 2008/12/1

Y1 - 2008/12/1

N2 - Introduction: We have shown that sputum is a feasible biofluid for analysis of biomarkers using Fourier transform infrared (FTIR) spectroscopic analysis and that FTIR can detect different patterns of metabolites between patients with lung cancer and healthy volunteers.1 Aim: To analyse further the FTIR spectrometric patterns in more patients with lung cancer and also smokers deemed 'high risk'. To identify what actual compounds may differentiate cancer from non-cancer sputum samples. Methods: Loco-regional ethical permission was obtained.

AB - Introduction: We have shown that sputum is a feasible biofluid for analysis of biomarkers using Fourier transform infrared (FTIR) spectroscopic analysis and that FTIR can detect different patterns of metabolites between patients with lung cancer and healthy volunteers.1 Aim: To analyse further the FTIR spectrometric patterns in more patients with lung cancer and also smokers deemed 'high risk'. To identify what actual compounds may differentiate cancer from non-cancer sputum samples. Methods: Loco-regional ethical permission was obtained.

M3 - Conference Proceeding (Non-Journal item)

SP - A60-A61

BT - Winter Meeting of the British-Thoracic-Society

T2 - Winter Meeting of the British-Thoracic-Society

Y2 - 3 December 2008 through 5 December 2008

ER -

Fourier transform infrared spectroscopy and metabolic profiling in lung cancer

Abstract

Conference

UN SDGs

Access to Document

Permanent link

Fingerprint

Cite this